Global Industrial Gearbox Market Projected to Reach USD 47.16 billion by 2033, With a 4.6% CAGR

The industrial gearbox market is predicted to be worth USD 30.08 billion in 2023, and rise to USD 47.16 billion by 2033. Demand is expected to increase at a CAGR of 4.6% during the projected period.

Given that industrial gearboxes are used to control the speed and torque of production-related machinery and components, demand for these gearboxes is expected to rise as smart manufacturing becomes more common.

The adoption of smart manufacturing is anticipated to raise the sales of industrial gearboxes, which are a crucial component of the industrial automation process. As the robotics industry develops and new technologies become available, manufacturers are likely to expect higher profit margins. Due to this technology, industrial gearbox makers now have greater opportunities.

With the ability to precisely control the movements of industrial robots, gearboxes can be made to provide more precise motion control for industrial processes. Governments of different nations have taken a number of steps to support the industrial gearbox growth in sector. In order to do this, financial incentives must be provided for the use of energy-efficient technology, such as industrial gearboxes, as well as sector-specific research and development programs.

Browse Full Report Here

Manufacturers are focusing on designing robust and effective gearboxes for power applications. The market participants also stand to gain financially from the increase in demand for energy-efficient equipment. Producers of industrial gearboxes are focusing on developing technologically advanced gearboxes since they hasten market expansion.

Key Takeaways From The Industrial Gearbox Market Report:

  • By 2033, the United States is likely to rule the industrial gearbox market, with a CAGR of 5.1%.
  • The industrial gearbox market increased at a 4.3% CAGR between 2016 and 2022, citing FMI’s study.
  • The industrial gearbox market was expanding, with a value of US$ 28.75 billion in 2022.
  • The expansion in China is anticipated to expand at an adequate CAGR of 9.5% by 2033.
  • Japan’s industrial gearbox market is expected to expand significantly, with a CAGR of 4.5% by 2033.
  • In 2023, the industrial gearbox sector is likely to increase in India with a size of US$ 15.56 billion.
  • The expansion in the United Kingdom is anticipated to expand at an adequate CAGR of 5.1% by 2033.
  • Based on type, the helical industrial gearbox led the market share in 2022, and continues to dominate the sector during the forecast period.
  • Based on design, the parallel axis segment is projected to lead the market by 2033.
  • Based on end user, the power generation sector led the market share in 2022, and continues to dominate the sector during the forecast period.

Key Strategies in the Industry

In order to remain competitive, businesses constantly innovate to provide their customers with high-quality products and services. Fundamental market players frequently announce significant business decisions, which have a favorable or negative impact on the market.

  • The Nidec Corporation created an automated guided vehicle with a vision-based tracking system in August 2020. By concentrating on the device, among other things, the team at Nidec Committed Shimpo has contributed to improving productivity, automation, and development.
  • Nanjing High Accurate Drive Equipment Manufacturing Group Co. Ltd received an order for 656 gearboxes in March 2021, specifically for the PDM460 dual stage gearboxes.

Competitive Environment

Competitors Seek Innovation to Gain a Foothold in the Market

To remain competitive, businesses must constantly innovate in order to provide high-quality goods and services to their customers. They spend a lot of money on research and development to stay ahead of their competitors and create new products and innovations.

They are also focusing on cost-cutting initiatives in order to reduce their overall manufacturing costs and maintain their competitiveness. Companies are also focusing on expanding their geographic reach in order to gain access to new markets and clients.

Key players:

  1. Bonfiglioli SPA
  2. Sumitomo Heavy Industries
  3. SEW Eurodrive
  4. Nidec Motor Corporation
  5. Bauer Gear GmbH
  6. Emerson Electric
  7. Elecon Engineering Co. Ltd
  8. Dana Brevini Power Transmission
  9. Johnson Electric Holding Limited
  10. Flender GmbH
  11. Comer Industries S.p.A.
  12. China High-Speed Transmission Equipment Group Co., Ltd

Industrial Gearbox Market Segmentation:

 By Type:

  • Helical
  • Planetary
  • Bevel
  • Worm
  • Spur (in-line)

By Design

  • Parallel Axis
  • Angular Axis
  • Others

By End User

  • Material Handling
  • Construction
  • Power Generation
  • Mining
  • Food & Beverage
  • Manufacturing Industry
  • Packaging & Labeling
  • Others

By Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia Pacific
  • Middle East and Africa

About the Author:

Nikhil Kaitwade (Associate Vice President at Future Market Insights, Inc.) has over a decade of experience in market research and business consulting. He has successfully delivered 1500+ client assignments, predominantly in Automotive, Chemicals, Industrial Equipment, Oil & Gas, and Service industries.

His core competency circles around developing research methodology, creating a unique analysis framework, statistical data models for pricing analysis, competition mapping, and market feasibility analysis. His expertise also extends wide and beyond analysis, advising clients on identifying growth potential in established and niche market segments, investment/divestment decisions, and market entry decision-making.

Nikhil holds an MBA degree in Marketing and IT and a Graduate in Mechanical Engineering. Nikhil has authored several publications and quoted in journals like EMS Now, EPR Magazine, and EE Times.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer, Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Oil Filled Transformer Market to Reach US$ 73.98 Billion by 2033, Projected to Grow at a 6.5% CAGR

The Oil-Filled Transformer Market is experiencing rapid expansion driven by a confluence of factors, including the global trends of urbanization, modernization, population growth, and fast-paced infrastructural development. Additionally, the rising demand for electricity due to increasing power consumption, coupled with the growing adoption of renewable energy sources and extensive network development, is fueling the remarkable growth in this sector.

The oil-filled transformer market is expected to be valued at US$ 39.41 billion in 2023, rising to US$ 73.98 billion by 2033. During the forecast period, the market is expected to grow at a CAGR of 6.5%.

The expanding need for oil-filled transformers is being driven by urbanisation, modernisation, population growth, and fast infrastructural development. Furthermore, rising power consumption, renewable energy, and network development are propelling market growth. Furthermore, greater awareness of the importance of upgrading obsolete energy systems and implementing smart grids is boosting the use of oil-filled transformers.

Emerging economies in several developing countries and growing technical advancement are flourishing market opportunities. End-users demand power generation and distribution on a large scale are increasing the demand for oil filled transformer. Furthermore, manufacturers are expanding electricity infrastructure and refurbishing grid networks which is boosting the sales of oil filled transformer.

Browse Full Report Here

Rise in Electricity Trade on International Level Uplift Market Opportunities

The growing population all around the globe is increasing the electricity demand and thereby increasing the consumption of oil filled transformers. High electricity consumption in various populated nations such as China, India, and the United States propels market opportunities. The innovation of smart grid to provide strength and reduce the load are expected to increase the adoption of oil filled transformer.

India is among the nations that produce electric power in vast quantities. The country supplies electricity to neighboring international border countries, including Sri Lanka, Bhutan, Myanmar, and Bangladesh. Similarly, several other developing & developed countries are expanding their business to acquire maximum output. Therefore, innovations in transmission, electric equipment, and switching gears drive global market growth.

Key Takeaways:

  • Robust Market Growth: The global oil filled transformer market is set to expand from US$ 39.41 billion in 2023 to a projected US$ 73.98 billion by 2033.
  • Renewable Energy Surge: Growing adoption of renewable energy sources is a major driver fueling the demand for oil filled transformers.
  • UK Market Momentum: The United Kingdom’s oil filled transformer market is forecasted to grow at a steady CAGR of 7%.
  • Strategic Industry Players: Key companies like Kitashibe Electric Co. Ltd., Elsewedy Electric, and LS Electric Co. Ltd. are leading the market.
  • Modern Network Integration: Advancements in smart grid technologies are accelerating the need for efficient oil filled transformers.
  • International Trade Influence: Increasing international trade is playing a crucial role in driving the market’s expansion.

Who is Winning?

The key players are playing a crucial role in the global market. These players are trying to launch advanced innovative products to satisfy consumers’ requirements. In addition, the prominent players are concerned about the environment and develop non-toxic products.

The leading players invest in the latest technologies to build advanced products and upsurge the market by acquiring maximum output. In addition, these players adopt marketing tactics, including mergers, collaborations, product launches, partnerships, and acquisitions.

Other Prominent Players in the Market are:

  • General Electric
  • Schneider Electric
  • CG Power & Industrial Solutions Ltd
  • Fuji Electric Co. Ltd
  • Toshiba International Corporation
  • Kitashibe Electric Co. Ltd.
  • Elsewedy Electric
  • LS Electric Co. Ltd.
  • Lemi Trafo Transformers
  • Mettz Group
  • Ormazable San
  • Mettz Group
  • Celme s.r.l.
  • Eaton
  • Kirloskar Electric
  • Kotsons Pvt. Ltd.
  • ABB Ltd
  • Bharti Heavy Electricals Ltd.
  • Schneider Electric SE
  • Jinan International USA Ltd.
  • Siemens AG

Recent Developments in the Market:

  • In Jan 2019, Hammond Power Solutions launched a three-phase transformer for industrial use to prevent harsh environments and ingress of moisture.
  • In July 2018, ABB Ltd., an automation and electrification company, acquired GE Industries for US$ 2.6 billion. This acquisition expands ABB’s position worldwide.

Oil Filled Transformer Market by Category

By Core:

  • Berry
  • Closed
  • Shell

By Winding:

  • w Auto-transformer
  • T o Winding

By Product Type:

  • Instrument Transformer
  • Distribution Transformer
  • Power Transformer
  • Others

By Modes of Cooling:

  • Oil Natural Air Natural
  • Oil Natural Air Forced
  • Oil Natural Water Forced

By Substation Connectivity:

  • Transmission
  • Distribution

By Rating:

  • < 5 MVA
  • > 5 MVA to < 10 MVA
  • > 10 MVA

By Mounting:

  • Pad
  • Pole
  • Foundation
  • Others

By Application:

  • Utility
  • Residential
  • Commercial & Industrial

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia & Pacific
  • East Asia
  • The Middle East & Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer, Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Printed Circuit Boards (PCBs) Market Set to Surge, Reaching US$ 104.8 Billion by 2033 with a 5.1% CAGR from 2023 to 2033

The global printed circuit boards market is on a trajectory to attain a valuation of US$ 60.2 billion in 2022, with sustained demand anticipated throughout the assessment period. This robust demand is rooted in the rapid evolution of technology and the exponential growth of consumer electronics. By 2033, the market is projected to achieve a substantial value of US$ 104.8 billion, driven by a notable Compound Annual Growth Rate (CAGR) of 5.1% from 2023 to 2033. Anticipated revenues for the year 2023 stand at US$ 63.5 billion.

The relentless progress in consumer electronics, encompassing smartphones, tablets, gaming consoles, and smart home devices, serves as a pivotal driver behind the printed circuit boards (PCBs) market. The escalating need for compact yet high-performance PCBs further amplifies the market’s expansion.

Browse Full Report Here

The Surge in Miniaturization of IoT Devices and Compact Electronic Gadgets Drives Printed Circuit Boards (PCBs) Market

The growing demand for miniaturization in IoT devices and compact electronic products, encompassing wearables, IoT devices, and medical equipment, significantly bolsters the expansion of the printed circuit boards (PCBs) market.

North America Poised to Lead the Printed Circuit Boards Market with Pioneering Consumer Electronics Innovations

The dominance of the printed circuit boards market by North America is attributed to remarkable technological advancements in consumer electronics within the region. Countries like India, China, and South Korea also play a pivotal role in propelling the growth of the printed circuit boards market.

Key Insights from the Printed Circuit Boards (PCBs) Market:

  • The period from 2018 to 2022 witnessed a robust demand growth in the printed circuit boards market, with a CAGR of 6.5%.
  • The multi-layer segment holds a significant CAGR of 4.9% based on type.
  • The standard multilayer segment within substrate types is projected to expand at a CAGR of 4.7% throughout the forecast duration.
  • North America is poised to emerge as a promising printed circuit board market, with a projected CAGR of 5.1%.
  • The printed circuit boards (PCBs) industry in the United Kingdom is anticipated to reach a market value of US$ 3.9 billion by 2033.
  • Asia Pacific stands as an opportunistic market for printed circuit boards, expected to capture a CAGR of 5.1% during the forecast period.
  • South Korea’s printed circuit industry is predicted to achieve a market revenue of US$ 5.1 billion by 2033.

Insight from an FMI Analyst:

“Growing technological innovation in manufacturing technology and increased awareness in the industrial sector are expected to drive the market in the forecast period. The increasing demand from the aerospace & defence sector globally is projected to play a vital role in strengthening the market,” according to an analyst at Future Market Insights (FMI).

Competitive Landscape:

Leading market players in the printed circuit boards (PCBs) market include Amperex Technology Ltd., Apex Microelectronics Company Limited, Amphenol Corporation, Autosplice, Inc., and Auter Electronics Ltd. Notable recent developments in the market include:

  • In November 2021, Aurubis AG announced a recycling plant in Georgia, United States.
  • Japan-based Nippon Mektron has been actively investing in research and development to enhance its PCB technologies, particularly for high-speed, high-frequency PCBs needed in 5G infrastructure and automotive electronics.
  • Zhen Ding Technology, a prominent PCB manufacturer, specializes in advanced PCB technologies for applications like smartphones, tablets, and automotive electronics. The company has been expanding its production capacity and exploring partnerships to meet the growing demand for advanced PCBs.

Key Segmentation:

By Type:

  • Multi-Layer
  • Double-Sided
  • Single-Sided

By Substrate Type:

  • Standard Multilayer
  • HighDensity Interconnect (HDI)
  • IC Substrate
  • Regid 1-2 Sided
  • Regid Flex
  • Others

By End-Use:

  • Computer & Peripherals
  • Communications
  • Consumer Electronic
  • Industrial Electronics
  • Automotive
  • Aerospace & Defence
  • Others

By Region:

  • North American
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us :

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports

Global Vacuum Cleaner Filter Market Set for Robust Growth, Projected to Reach Nearly US$ 4,670 million by 2032 with a CAGR of 9.3%

According to Future Market Insights (FMI) observations, the global vacuum cleaner filter market was valued at US$ 1924.1 million in 2022. The report estimates the market to expand at a positive CAGR of 9.3% from 2022 to 2032. During this period, it is projected that the rising awareness among end users, growing demand for vacuum cleaners from the healthcare sectors, and changing lifestyles will drive the market for vacuum cleaner filters.

The expansion of the global economy is speeding up urbanization across developing countries. This is resulting in increasing disposable incomes, giving consumers the required purchasing power to invest in vacuum cleaners equipped with the latest filtration technologies.

Vacuum cleaner filters allow vacuum cleaners to do their jobs properly. They can keep contaminants and airborne particles intact and filter air to ensure thorough cleaning. As adoption of vacuum cleaners is set to increase across commercial, industrial, and residential sectors, the global market for vacuum cleaner filters is set to register substantial acceleration.

Browse Full Report Here

Key Takeaways from Market Study

  • By filter type, the cartridge filters segment is anticipated to witness prominent demand expansion at 8.9% CAGR by value from 2022 to 2032.
  • By sales channel, the OEM sales segment is projected to expand at a CAGR of 9.1% by value between 2022 and 2032.
  • By vacuum cleaner type, the upright vacuum cleaner segment is projected to expand at a CAGR of 7.8% by value.
  • By region, North America is anticipated to witness substantial growth in the vacuum cleaner filter market.
  • By end use industry, the residential sector is estimated to hold a prominent volume share of 64.4% in 2022.

“The market for vacuum cleaner filters is being fueled by rising demand from the healthcare and commercial sector and increasing dependency on convenient household appliances. Shifting preferences toward technologically advanced goods and appliances are fueling demand. Prominent manufacturers involved in the market are introducing new and trending technologies like highly efficient filters and advanced filters for custom applications” Says an FMI analyst.

Who is Winning ?

A few of the key players in vacuum cleaner filter market include American Air Filter Company Inc Rotronic AG, APC Filtration Inc, Bissell Inc, Dyson, Electrolux AB, Freudenberg Filtration Technologies GmbH & Co, GVS S, Hengst SE, M-Filter Group, Midea Group, Nilfisk, Robert Bosch GmbH, and TTI, Inc.

Key players are also keen on developing innovative vacuum cleaner filter products, which are aimed at being cost-effective without compromising on vacuum cleaner performance. Market participants are also making hefty investments in mergers, acquisitions, strategic collaborations, and expansion to strengthen their respective footholds in the global market.

Global Vacuum Cleaner Filter Industry by Category

By Filter Type:

  • Bag Filters
  • Foam Filters
  • Cyclone Filters
  • Cartridge Filters
  • Cloth Filters

By Sales Channel:

  • OEM (First Fit)
  • Aftermarket (Replacement)

By Vacuum Cleaner:

  • Upright
  • Canister
  • Central
  • Wet/Dry
  • Robotic

By End Use:

  • Industrial
  • Residential
  • Commercial

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia Pacific
  • Middle East and Africa

About the Author:

Nikhil Kaitwade (Associate Vice President at Future Market Insights, Inc.) has over a decade of experience in market research and business consulting. He has successfully delivered 1500+ client assignments, predominantly in Automotive, Chemicals, Industrial Equipment, Oil & Gas, and Service industries.

His core competency circles around developing research methodology, creating a unique analysis framework, statistical data models for pricing analysis, competition mapping, and market feasibility analysis. His expertise also extends wide and beyond analysis, advising clients on identifying growth potential in established and niche market segments, investment/divestment decisions, and market entry decision-making.

Nikhil holds an MBA degree in Marketing and IT and a Graduate in Mechanical Engineering. Nikhil has authored several publications and quoted in journals like EMS Now, EPR Magazine, and EE Times.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer, Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Patient Transportation Market Projected to Grow to USD 37,639.9 Million by 2034 at a 5.5% of CAGR

Patient Transportation Market
Patient Transportation Market

The global patient transportation market is on a robust growth trajectory, with an estimated valuation of USD 22,035.5 million in 2024. The market is expected to expand significantly, reaching USD 37,639.9 million by 2034, reflecting a compound annual growth rate (CAGR) of 5.5% over the forecast period.

In 2023, the revenue generated from non-emergency patient transportation reached USD 20,886.8 million, highlighting the substantial role this segment plays within the broader patient transportation industry. The sector is anticipated to experience a year-over-year growth rate of 5.5% in 2024, driven by increased demand for both emergency and non-emergency transportation services.

Because of efficiency in the management of critical care and long-term care patients in mobility, positioning, and transfer, sales in the market are expected to grow. Apart from that, chronically ill patients are given alternatives for transportation to and from medical facilities. These instances are provisional, based on reimbursements for patient transportation equipment capabilities, as determined by the patient’s insurance coverage, or government-funded initiatives.

The market for patient transportation is likely to gain traction, especially with the high prevalence of chronic diseases, high volumes of trauma-related cases, and disabilities. In cases where bariatric and diabetic patients require caregiver assistance for mobility, patient transportation solutions provide assistance.

To offer a diverse product range, manufacturers in the patient transportation market are developing products which are engineered as per disease indication. Key competitors have maintained a leading position in the market by integrating smart technologies into existing product offerings. 

Several firms are also promoting equipment sales through integration and collaboration with medical service providers, such as hospitals, which in turn is expected to boost sales in the market over the forecast period.

“Rising availability of indication-specific patient transportation solutions, along with the integration of connective technology such as artificial intelligence (AI) and IoT in beds and chairs will push sales in the market in the forthcoming years,” says an FMI analyst.

Key Takeaways:

  • Based on application, the non-emergency transportation held about 47.4% of the total market share in 2021, and the trend is expected to continue over the forecast period. 
  • In terms of end users, the hospitals segment accounted for 45.9% of the total market share in 2021. 
  • Sales in the U.S. patient transportation market are projected to increase at a 6.3% CAGR over the assessment period. 
  • Germany will witness high demand for patient transportation solutions, rising at a 6% CAGR through 2032. 
  • China will continue dominating the East Asia patient transportation market, with sales growing at a 5.9% CAGR over the forecast period. 

Competition Landscape 

Key players operating in the global patient transportation market are improve their product portfolios by incorporating breakthrough technologies for comprehensive patient care throughout the transportation process. In addition to this, the newly developed products can be personalised for use in response to certain disease-related events. For instance:

  • Stryker launched the industry’s first linked ambulance cot in March 2022, building on the success of its predecessor, the Power-PRO 2 powered ambulance cot. Greater manoeuvrability, improved safety, and connectivity tools are all part of the new development, which will help to mitigate time and cost constraints.
  • In December 2021, Vendlet launched a new powered patient turning aid.

Key Players :

  • Envision Healthcare
  • London Ambulance Service NHS Trust
  • Acadian Ambulance Service
  • BVG India Limited
  • America Patient Transport Services, Inc
  • Falck Denmark A/S
  • Air Medical Group Holdings, Inc.
  • Air Methods Corporation
  • Ziqitza Healthcare Limited
  • Medivic Aviation

A Old Full Report Analysis Click Here

Market Segments Covered in Patient Transport Services Market Analysis

By Transport Vehicle:

  • Ground Ambulance
  • Air Ambulance
  • Water Ambulance

By Emergency Services Type:

  • Emergency Services
  • Non-emergency Services

By Equipment Type:

  • Advanced Life Support (ALS) Patient Transport Services
  • Basic Life Support (BLS) Patient Transport Services

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges clients face and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Alzheimer’s Therapeutics Market Projected to Reach USD 7,359.7 Million by 2033 at a 9.2% of CAGR

Global Alzheimer’s Therapeutics Industry
Global Alzheimer’s Therapeutics Market

The global Alzheimer’s therapeutics market is on a strong growth trajectory, with an expected valuation of USD 3,052.3 million in 2023. According to recent forecasts, the market is set to expand at a compound annual growth rate (CAGR) of 9.2%, reaching a substantial USD 7,359.7 million by 2033.

Alzheimer’s disease, a progressive neurological disorder that affects millions worldwide, has driven an increasing demand for effective therapeutics. The projected market growth reflects the ongoing advancements in drug development, heightened investment in research, and the urgent need for innovative treatments to manage and potentially cure this debilitating condition.

Therapies for Alzheimer’s therapeutics offer temporary and uncertain improvements in the well-being of individuals, and none of the approved drugs can modify the course of the disease Alzheimer’s Therapeutics cement. Thus, the magnitude of the affected population and the lack of suitable and effective treatment offers an incredible opportunity for drug manufacturers.

However, the identification of the primary reasons and mechanisms involved in Alzheimer’s therapeutics is limited. Drug manufacturers have been unable to validate the significant clinical benefits of treatment for numerous new compounds due to strict regulations. One of the significant trends observed in this market is the collaboration of the existing players.

Precisely, diagnostic technology companies are carefully trying to bring about effective biomarker technologies to support and improve the drug development process for potential drug candidates, which is further expected to propel the demand.

Developing countries are expected to offer lucrative opportunities for this market. According to Alzheimer’s Therapeutics International in 2015, 58% of people with dementia live in developing countries, but by 2050 this will rise to 68%. The fastest growth in the elderly population is taking place in China, India, and their South Asian and Western Pacific region.

According to the World Alzheimer Report in 2015, regional estimations of dementia prevalence in people aged 60 years and over vary from 4.6% in Central Europe to 8.7% in North Africa and the Middle East, however, all other regional estimates fall in relatively between 5.6% and 7.6%.

The top 17 Key Players Covered in the Alzheimer’s Therapeutics Market are:

  1. AbbVie, Inc.
  2. Teva Pharmaceuticals Ltd.
  3. Eisai Co., Ltd.
  4. Janssen Pharmaceuticals, Inc. (Johnson & Johnson)
  5. Novartis AG
  6. Zydus Lifesciences Ltd (CADILA)
  7. Sun Pharmaceutical Industries Ltd.
  8. Dr. Reddy’s Laboratories Ltd
  9. Aurobindo Pharma Ltd
  10. Amneal Pharmaceuticals Inc.
  11. Macleods Pharmaceuticals Ltd.
  12. Viatris Inc.
  13. Lupin Ltd
  14. Cipla Ltd.
  15. Torrent Pharmaceuticals Ltd.
  16. Unichem laboratories ltd
  17. Lannett Inc.

A Old Full Report Analysis Click Here

Key Segments Covered in Alzheimer’s Therapeutics Market Research

By Drug Name:

  • Donepezil
  • Rivastigmine
  • Memantine
  • Galantamine
  • Manufactured a combination of memantine and donepezil

By Drug Class:

  • Cholinesterase Inhibitors
  • NMDA Receptor Antagonists
  • Manufactured Combination

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacies

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges clients face and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Extraction Kits Market Poised for Robust Growth, Projected to Reach USD 2,556.6 Million by 2033 at a 7.1% of CAGR

Extraction Kits Market
Extraction Kits Market

The global extraction kits market is set for significant expansion, with an anticipated growth rate of 7.1% CAGR over the forecast period. The market size is estimated to reach a substantial valuation of USD 1,293.4 million by the end of 2023.

A recent study highlights that DNA extraction kits are a major driver of this growth, holding a notable 49.88% share of the global market in 2022. The dominance of DNA extraction kits underscores their critical role in various applications, including medical research, diagnostics, and biotechnology.

Moreover, an upsurge in the number of research and development activities that focus on developing the fastest vaccines to combat various infectious diseases will further prompt growth in the target market. In addition to this, several other initiatives like the EMBO, and Young Investigator Program assists with the establishment of laboratories by life scientists. All similar research initiatives will support the leading market players to develop their businesses in emerging economies, attract lucrative opportunities, and invite overall target market growth during the forecast period.

“Increasing funding in life sciences and investment for molecular diagnostics will generate growth opportunities for the global extraction kits market over the forecast period,” says an FMI analyst.  

Key Takeaways:

  • Dearth of expert personnel and strict regulatory measures may stymie the market growth.
  • The U.S’s extraction kits market is predicted to present notable growth during 2022-2032.
  • The extraction kits market in Germany will register a CAGR of 8.3% during the forecast period.
  • China’s extraction kits market will grow at a CAGR of 9.7% during 2022-2032.
  • The DNA extraction kits segment accounted for 49.7% of the market share and will grow at 7.4% CAGR during the assessment period.
  • On the basis of application, the disease diagnosis segment will account for 36.0% revenue share.

Competitive Landscape in the Global Extraction Kits Industry 

  • Bio Rad Laboratories Inc.
  • Thermo Fisher Scientific
  • Promega Corporation
  • Agilent Technologies
  • Bioneer Corporation
  • PerkinElmer Inc.
  • LGC Biosearch Technologies
  • Qiagen
  • General Biosystems
  • Takara Bio Inc.
  • Roche Life Science
  • GeneReach Biotechnology Corporation.
  • Merck Millipore
  • BioFire Defense LLC
  • Akonni Biosystems, Inc
  • Primerdesign Ltd.

Key market participants are concentrating on increasing their sales in emerging economies. These enterprises are keen on new product releases and strategic collaboration to improve their revenue.

A Old Full Report Analysis Click Here

Key Market Segments Covered in Global Extraction Kits Industry Research

By Product:

  • DNA Extraction Kits
    • Sequence-specific DNA
    • Cell-free DNA (cfDNA)
    • Tissue DNA Extraction Kits
  • RNA extraction Kits
    • Total RNA
    • Purified RNAs
    • Viral RNA
    • Sequence-specific RNA
  • Total nucleic acid (RNA + DNA)

By Application:

  • Disease Diagnosis
  • Drug Discovery
  • Cancer Research
  • cDNA Library
  • Others

By End User:

  • Hospitals
  • Academic and Research Institutions
  • Pharmaceutical and Biotechnology Companies
  • Clinical Research Organisations
  • Diagnostic Laboratories
  • Forensic Labs

 Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Bacteriophage Market Set for Steady Growth, Projected to Reach USD 68 Million by 2033 at a 4.2% of CAGR

Bacteriophage Market
Global Bacteriophage Market

The global bacteriophage market is experiencing notable momentum, with a current valuation of USD 45.07 million in 2023. According to recent projections, the market is expected to grow steadily, reaching USD 68 million by 2033. This growth is anticipated at a compound annual growth rate (CAGR) of 4.2% over the forecast period.

Bacteriophages, or phages, are viruses that target and destroy specific bacteria, offering a promising alternative to traditional antibiotics, particularly in the face of rising antimicrobial resistance. As the global healthcare industry increasingly turns to innovative solutions to combat bacterial infections, the demand for bacteriophage-based therapies is gaining momentum.

Phage probiotics are increasingly in demand since they have many advantages over conventional probiotics. This is driving the market’s expansion. In order to maintain a healthy gut, phage probiotics encourage the growth of beneficial gut bacteria over bad gut bacteria. The market is expanding more rapidly as novel treatment options for infections caused by bacteria resistant to antibiotics are being developed. Growing public knowledge of the use of bacteriophage probiotics for those with immune-mediated digestive problems and bowel problems will also help the industry.

Surging demand for phage probiotics has encouraged the key players in the market to up their game by increasing investment in research and development (R&D) for new bacteriophages. In comparison to antibiotics, bacteriophages possess high host specificity, they exhibit good benefits with single hit kinetics, are self-replicating and also possess anti-biofilm properties.

As per FMI, gastroenterology is the most sought after application of phage probiotics, as phage probiotics are administered by doctors since phage therapeutics do not get early clearance from regulatory authorities in many developing regions.

Bacteriophage probiotics are mostly administered via the oral route since it is non- invasive, shows immediate release and is cost effective. These probiotics are widely available in retail pharmacies, thereby, boosting the sales in developing nations.

Key Takeaways from Market Study

  • Phage probiotics are expected to hold over 95% market value share in 2021, and are expected to display a CAGR growth of 4.2% over the forecast period.
  • The oral route of administration accounted for over 96% of market share in 2021 and is expected to hold a market share by value of 97.2% by 2031.
  • In terms of application, gastroenterology registered growth at a CAGR of 4.3% in 2021, with a market share of 93.8%.
  • Retail pharmacies will hold a higher share in the bacteriophage market due to presence of large chain of retail pharmacies and easy availability of pharma products
  • Europe is slated to be the largest leading region with a value share of 43% by the end of the forecast period due to presence of large healthcare infrastructure and strong R&D centers.

“With rising prevalence of antibacterial resistance, the bacteriophage market is expected to witness steady growth over the forecast period. To curb the global burden, key players are likely to invest extensively in R&D activities to develop effective phage probiotics” says an analyst of Future Market Insights.

Market Competition

Acquisitions, expansion, development of an extensive product pipeline and product launches are the key strategies adopted by manufacturers to increase their revenue and expand their consumer base in different geographies.

  • In August 2021, Carillon Miami Wellness Resort partnered with the biostation to launch a new functional medicine practice located at the resort’s award-winning, 70,000-square-foot spa and wellness facility.
  • In February 2020, Microgen’s Bacteriophage products have been included into clinical recommendations for urology.

Want more insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global bacteriophage market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on bacteriophage market segment based on product – (phage probiotics, phage therapeutics), by route of administration- (oral, topical, others), by application (gastroenterology, respiratory infections treatment, skin infection treatment, wound prophylaxis, urogenital infection treatment, others), by distribution channel (retail pharmacies, hospital pharmacies, online pharmacies) and across seven major regions.

Key Players:

  • Life extension
  • Arthur Andrew Medical
  • Deerland Probiotics & Enzymes Inc.
  • BioChimpharm
  • Micreos Human Health
  • Designs for Health
  • Accelerated Health Systems LLC
  • The biostation
  • Microgen
  • IntraLytix Inc.

A Old Full Report Analysis Click Here

Key Market Segments Covered In Bacteriophage Industry Research

By Product:

  • Phage Probiotics
  • Phage Therapeutics

By Route of Administration:

  • Oral
  • Topical
  • Other

By Application:

  • Gastroeneterology
  • Respiratory infections market
  • Skin infection treatment
  • Wound prophylaxis
  • Urogenital infection treatment
  • Others

By Distribution Channel:

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

eClinical Solutions and Software Market Poised for Exponential Growth, Anticipates USD 29.1 Billion Valuation by 2033 at a 12.1% of CAGR

Global eClinical Solutions and Software Industry
Global eClinical Solutions and Software Market

The global eClinical Solutions and Software Market set to achieve a remarkable valuation of USD 9.3 billion by the end of 2023, with projections indicating a substantial expansion at a compound annual growth rate (CAGR) of 12.1%. By 2033, the market is expected to reach a staggering USD 29.1 billion, according to a recent study by Future Market Insights.

One of the key drivers behind this impressive growth is the dominance of Clinical Data Management Systems (CDMS), which are anticipated to hold a notable 22.6% share of the global market in 2023. CDMS play a crucial role in streamlining clinical trials and managing large volumes of data, enhancing the efficiency and accuracy of clinical research processes.

The significant market expansion reflects increasing investments in healthcare technology, a growing demand for data-driven decision-making, and a rising emphasis on the digitization of clinical data management. As organizations and institutions strive to improve research outcomes and operational efficiency, CDMS has emerged as a pivotal component in the evolving landscape of clinical research and development.

The expansion of research and development activities by biopharmaceutical and pharmaceutical businesses will prompt the use of eClinical solutions and software in various clinical trials which will foster growth for the market. This is primarily due to the fact that in order to address certain contemporary eClinical trial management needs, many businesses will require a comprehensive eClinical platform that will adapt to required needs. Hence, the prospects for the Global eClinical Solutions and Software Industry look bright in the upcoming years.

With the surge in the amount of data produced via the clinical development process, the need for efficient tracking and evaluation of clinical data will also rise. As a result of this, the demand for eClinical solutions and software amplifies in clinical trials which, in turn, supplements the overall market growth. The eClinical solutions and software increase efficiency, lessen the expenditure, and errors like duplicate entry are avoided due to the use of eClinical technologies. This factor bodes well for the expansion of the Global eClinical Solutions and Software Industry size. Other factors that will aid the market growth are the progress witnessed in the life sciences field and the outsourcing of clinical trials to contract research organizations (CROs). All of these factors propel the Global eClinical Solutions and Software Industry forward during the projection period.

Key Takeaways:

  • High costs and constant maintenance expenditure will prevent the growth of the eClinical solutions and software market during the assessment period.
  • Based on the service, the clinical data management systems (CDMS) category will dominate the global market with an estimated share of 22.6% for 2023 and 2033.
  • By delivery mode, the web-hosted (on-demand) will lead the market with a share of 67.3%.
  • The eClinical solutions and software market in the US will hold about 39.3% of the market share in 2023 due to increasing product launches by key players.
  • China’s eClinical solutions and software market will expand at a strong CAGR of 8.7% owing to greater medical needs.

Competitive Landscape 

Oracle, Datatrak International, Inc., CRF Health, eClinicalWorks, Parexel International Corporation, Bioclinica, IBM Watson Health, and Anju Life Sciences Software, among others, are some of the dominant players in the Global eClinical Solutions and Software Industry profiled in the full version of the report.

In an intensely competitive environment, leading market players are concentrating on the swift adoption of advancing technology. These businesses employ various expansion strategies including mergers, collaborations, partnerships, and acquisitions, while also engaging in product development to enhance their market positions.

More Insights Into Global eClinical Solutions and Software Industry

In its latest report, FMI offers an unbiased and detailed analysis of the Global eClinical Solutions and Software Industry, providing historical data from 2017 to 2022 and forecast statistics for 2023 to 2033. For a comprehensive understanding of the global market potential, growth, and scope, the market is segmented on the basis of solution, delivery mode, clinical trial, end-user, and region.

According to the same reports, based on segmentation, the CROs category will make substantial contributions to the overall market growth in terms of end-users. In terms of clinical trials, the phase III segment will account for 46.7% of the global market share in 2023.

Based on region, the Global eClinical Solutions and Software Industry will present strong growth in the US. The target market in this region will account for 39.3% of the market share in 2023 and will likely continue this growth during the forecast period. Favorable government policies and rising funds from the government as well as increasing product launches from key players will push the market forward in the US. Germany and China, too, will make notable contributions to the global growth of the eClinical solutions and software market during the forecast period.

Key Players:

  1. Oracle
  2. Datatrak International, Inc.
  3. Dassault Systemes
  4. CRF Health
  5. eClinicalWorks
  6. Parexel International Corporation
  7. Bioclinica
  8. eClinical Solutions
  9. IBM Watson Health
  10. Anju Life Sciences Software
  11. ERT Clinical

A Old Full Report Analysis Click Here

Key Market Segments Covered in Global eClinical Solutions and Software Industry Research

Solution:

  • Randomization & Trial Management (RTSM)
  • Clinical Data Management System (CDSM)
  • Clinical Trial Management System (CLMS)
  • Electronic Clinical Outcome Assessment (eCOA)
  • Electronic Trial Master File (eTMF)
  • Electronic Data Capture
  • Others

Delivery Mode:

  • Licensed Enterprise (On-premise) Solution
  • Cloud-based (SAAS) Solution
  • Web-hosted (on-demand) Solution

Clinical Trial:

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Acute Kidney Injury Treatment Market Set for Remarkable Growth to an Impressive USD 3,566.7 Million by the End of 2029 with 8.2% CAGR

Acute Kidney Injury Treatment Market
Acute Kidney Injury Treatment Market

The global Acute Kidney Injury Treatment Market is poised for extraordinary expansion, with a projected compound annual growth rate (CAGR) of 8.2% from 2022 to 2029. This growth is driven by increasing awareness, advancements in medical technologies, and a rising global incidence of acute kidney injuries.

The market’s value is anticipated to soar from over USD 2,058.2 million in 2022 to an impressive USD 3,566.7 million by the end of 2029. This substantial increase reflects the heightened demand for innovative treatment options and the ongoing development of cutting-edge therapies aimed at addressing this critical health condition.

Acute Kidney Injury, a sudden loss of kidney function that can occur due to a variety of causes including injury, infection, or complications from other conditions, presents a significant healthcare challenge. The growing prevalence of this condition globally, combined with the introduction of advanced treatment modalities and supportive technologies, is driving market growth.

Industry experts attribute this robust market trajectory to several factors, including increased investment in research and development, enhanced diagnostic and monitoring technologies, and a surge in the number of patients requiring specialized care. Furthermore, the rise in geriatric populations and chronic diseases that predispose individuals to AKI are expected to further fuel demand for effective treatment solutions.

Key Takeaways:

  • Owing to increasing acute kidney injury prevalence, number of dialysis centres, and efficient treatment method, the dialysis segment is expected to be a significant revenue generator.
  • The intermittent haemodialysis segment, under product, in the acute kidney injury treatment market, is expected to be a prominent segment, as results provided by this treatment are more efficient as compared to other dialysis methods.
  • The pre-renal injury segment is anticipated to dominate the acute kidney injury treatment market, as pre-renal injury is more prevalent in patients with acute kidney injury.
  • North America is expected to dominate the global acute kidney injury treatment market in terms of revenue, owing to the growing adoption of advanced treatments over conventional methods. East Asia is expected to offer lucrative opportunities for the acute kidney injury treatment market during the forecast period.

Advanced Technology & Product Launches – Key Strategies Followed by Manufacturers

The participants in the acute renal injury treatment market are keeping up with advances in diagnostic technology and increased product availability in order to streamline their product offerings in respective regions with different product portfolios. For example, Fresenius Medical Care introduced the 4008A dialysis equipment in January 2022 in an effort to provide accessibility to dialysis treatment that is life-sustaining.

Competitive Landscape:

To provide patients with cutting-edge care, major companies in the worldwide acute renal injury treatment market are concentrating on creating automated, mobile, and tech-driven dialysis equipment. In order to broaden their range of products, they are also using cutting-edge technology like artificial intelligence and the Internet of Things (IoT).

In the meantime, several of the other firms are developing diagnostic technologies to simplify their product offers in emerging markets where their product portfolios are diversified.

For instance:

  • In March 2021, C-Path announced the launch of an acute kidney injury project in partnership with the USA Food and Drug Administration (FDA) for Drug Evaluation and Research, the Office of translational science, and the Division of cardiology and Nephrology, to develop a suite of prognostic tools to improve the detection of drug-induced kidney injury.
  • In June 2021, Abionyxx announced the enrollment of the first patient in its Phase-2a clinical study with CER-001 for the treatment of septic patients at high risk of developing acute kidney injury.

Key Companies Profiled:

  • Novartis, Pfizer Inc.
  • Merck & Co.
  • Biocon Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Mylan Pharmaceuticals Inc.
  • NIPRO Medical
  • Baxter Corporation
  • Asahi Kasei
  • NIKKISO
  • Fresenius Medical Care
  • Others

A Old Full Report Analysis Click Here

Acute Kidney Injury Treatment Market By Category:

Product:

  • Dialysis
    • Intermittent Hemodialysis
    • Continuous Renal Replacement Therapy (CRRT)
    • Sustained Low-Efficiency Dialysis (SLED)
  • Drug Therapy
    • Antibiotics
    • Diuretics
    • Immunosuppressive Agents

Injury:

  • Pre-renal Injury
  • Intrinsic Renal Injury
  • Post-renal Injury

Distribution Channel:

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa(MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube